-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ERNfomxAD1iJ3CtDmyQafqz6ti4G4VozNLrVNmgl7CD8UntbhbB8IB/Ksjo+jRHI RXKONIbwmIY/UiUKnFV7SQ== 0000950116-02-002740.txt : 20021204 0000950116-02-002740.hdr.sgml : 20021204 20021204084753 ACCESSION NUMBER: 0000950116-02-002740 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20021202 FILED AS OF DATE: 20021204 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: LEVITCH PETER CENTRAL INDEX KEY: 0001199203 RELATIONSHIP: DIRECTOR FILING VALUES: FORM TYPE: 4 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO STATE: A6 ZIP: 999999999 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 02847960 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 4 1 form4.txt FORM 4 FORM 4 [ ] Check this box if no ------------------------------------ longer subject to OMB APPROVAL Section 16. Form 4 or ------------------------------------ Form 5 obligations may OMB Number 3235-0287 continue. See Instruction 1(b) Expires: January 31, 2005 Estimated average burden hours per response 0.5 ------------------------------------ U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 (Print or Type Responses) - -------------------------------------------------------------------------------- 1. Name and Address of Reporting Person* Levitch Peter c/o Generex Biotechnology Corporation - -------------------------------------------------------------------------------- (Last) (First) (MI) 33 Harbour Square, Suite 202 - -------------------------------------------------------------------------------- (Street) Toronto, Ontario Canada M5J 2G2 - -------------------------------------------------------------------------------- (City) (State) (Zip) - -------------------------------------------------------------------------------- 2. Issuer Name and Ticker or Trading Symbol Generex Biotechnology Corporation (GNBT) - -------------------------------------------------------------------------------- 3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary) - -------------------------------------------------------------------------------- 4. Statement for Month/Day/Year | 5. If Amendment, Date of | Original (Month/Day/Year) | December 2, 2002 | - -------------------------------------------------------------------------------- 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) [ X ] Director [ ] 10% Owner [ ] Officer [ ] Other (specify below) (give title below) - -------------------------------------------------------------------------------- 7. Individual or Joint/Group Filing (Check Applicable Line) ____X___ Form filed by One Reporting Person ________ Form filed by More than One Reporting Person - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- TABLE I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned - --------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------- 1. Title of Security | 2. Trans- | 2A. | 3. Transaction Code | 4. Securities Acquired (A) or (Instr. 3) | action | Deemed | (Instr. 8) | Disposed of (D) | Date | Execution | | (Instr. 3, 4 and 5) | (Month/ | Date, if | | | Day/ | any | | | Year) | (Month/ | | | | Day/ | | | | Year) | | | | | | | | | | | | | | - ------------------------------------------------------------------------------------------------------------------------------------ | | | Code | V | Amount | (A)or | Price | | | | | | (D) | - ----------------------------------------------------------------------------------------------------------------------------------- Common Stock | 12/2/02 | -- | P | -- | 5,000 | A | $2.16 - ----------------------------------------------------------------------------------------------------------------------------------- Common Stock | 12/2/02 | -- | P | -- | 5,000 | A | $2.20 - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | ===================================================================================================================================
- ----------------------------------------------------------------------------------------------------------------------------------- 1. Title of Security | 5. Amount of Securities | 6. Ownership Form: | 7. Nature of Indirect Beneficial (Instr. 3) | Beneficially Owned | Direct (D) or | Ownership (Instr. 4) | Following Reported | Indirect (I) | | Transaction(s) | | | (Instr. 3 and 4) | (Instr. 4) | - ----------------------------------------------------------------------------------------------------------------------------------- Common Stock | | D | - ----------------------------------------------------------------------------------------------------------------------------------- Common Stock | 55,483 | D | - ----------------------------------------------------------------------------------------------------------------------------------- | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | ===================================================================================================================================
- ------------------------------------------------------------------------------- TABLE II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) - -------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------------------- 1. Title of Derivative | 2. Conversion or | 3. Transaction Date | 3A. Deemed | 4. Transaction | 5. Number of Derivative Security (Instr. 3) | Exercise Price | (Month/Day/Year) | Execution | Code (Instr.| Securities Acquired | of Derivative | | Date, if | 8) | (A) or Disposed of | Security | | any | | (D) (Instr. 3, 4 and 5) | | | (Month/ | | | | | Day/Year) | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | Code | V | (A) | (D) - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | | | ===================================================================================================================================
- ----------------------------------------------------------------------------------------------------------------------------------- 1. Title of Derivative Security | 6. Date Exercisable and | 7. Title and Amount of Underlying | 8. Price of Derivative (Instr. 3) | Expiration Date | Securities (Instr. 3 and 4) | Security (Instr. 5) | (Month/Day/Year) | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | Date | Expiration | Title | Amount or Number | | Exercisable | Date | | of Shares | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- | | | | | ===================================================================================================================================
- ------------------------------------------------------------------------------------------------------------------------------------ 1. Title of Derivative Security | 9. Number of Derivative | 10. Ownership Form of Derivative | 11. Nature of Indirect (Instr. 3) | Securities Beneficially | Securities: Direct (D) or | Beneficial Ownership | Owned Following Reported | Indirect (I) (Instr. 4) | (Instr. 4) | Transaction(s) (Instr. 4) | | - ------------------------------------------------------------------------------------------------------------------------------------ | | | - ------------------------------------------------------------------------------------------------------------------------------------ | | | - ------------------------------------------------------------------------------------------------------------------------------------ | | | - ------------------------------------------------------------------------------------------------------------------------------------ | | | - ------------------------------------------------------------------------------------------------------------------------------------ | | | - ------------------------------------------------------------------------------------------------------------------------------------ | | | - ------------------------------------------------------------------------------------------------------------------------------------ | | | - ------------------------------------------------------------------------------------------------------------------------------------ | | | - ------------------------------------------------------------------------------------------------------------------------------------ | | | - ------------------------------------------------------------------------------------------------------------------------------------ | | | ====================================================================================================================================
/s/ Peter Levitch December 3, 2002 - ------------------------------------ ---------------- **Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. -----END PRIVACY-ENHANCED MESSAGE-----